PMID: 42224238
A Hydrophobic Tag-Assisted Liquid-Phase Strategy for the Synthesis of Retatrutide.
Mao Chuan-Yu, Pang Zhao-Jiong, Qiao Guan-Yu et al.
Organic letters · 2026
Research Library
Retatrutide
48 papers indexed
PMID: 42296503
Benefits and Harms of Pharmacologic Treatments in Adults With Overweight or Obesity: A Living Systematic Review and Network Meta-analysis for the American College of Physicians.
Damen Johanna A A, Idema Demy L, Vernooij Robin W M et al.
Annals of internal medicine · 2026
PMID: 42208956
Beyond weight loss: multisystem benefits of obesity medications.
Savas Mesut, Kuckuck Susanne, Boon Mariëtte R et al.
The lancet. Diabetes & endocrinology · 2026
PMID: 41933725
Childhood obesity and cardiac risk in youth: Emerging challenges toward 2050.
Mishra Nikunja Kishor
Clinical nutrition ESPEN · 2026
PMID: 41787737
Comparative Efficacy and Safety of Glucagon Receptor Agonists on Metabolic Outcomes: A Network Meta-Analysis of Randomised Controlled Trials.
Abulehia Ayah, Ayesh Hazem, Ayesh Omar et al.
Endocrinology, diabetes & metabolism · 2026
PMID: 42419792
Comparative effects of drugs for adults with overweight or obesity: systematic review and network meta-analysis.
Nong Kailei, Shi Qingyang, Xie Xinran et al.
BMJ (Clinical research ed.) · 2026
PMID: 42559975
Composition and Labelling Accuracy of Products Sold as Retatrutide in Australia.
Piatkowski Timothy, Craven Alison, Cornell Samuel et al.
Drug and alcohol review · 2026
PMID: 41589220
Development of the Weight and Emotions Scale (WES).
Kanu Chisom, Kimel Miriam, Goetz Iris et al.
Obesity science & practice · 2026
PMID: 42198313
Diabetes Mellitus and Stroke: Pathophysiological Connections and Therapeutic Potential of GLP-1 and GLP-1/GIP Receptor Agonists.
Paceana Maria-Alexandra, Tartau Liliana Mititelu, Boboc Ianis Kevyn Stefan et al.
Pharmaceutics · 2026
PMID: 42219269
Do GLP-1 Receptor Agonists Sabotage Fat Grafts? : A Scoping Review of GLP-1 Receptor Agonist Effects on Adipocyte Biology and Implications for Autologous Fat Transfer.
Chalhoub Xavier, Yang Ng Zhi
Aesthetic surgery journal · 2026
PMID: 42168638
Dysesthesia associated with GLP-1 agonist therapies: data-mining analysis and literature review.
Laroche Marie-Laure, Géniaux Hélène, Jardou Manon
European journal of clinical pharmacology · 2026
PMID: 42371360
Effect of Retatrutide, a Novel Triple Receptor Agonist, on Blood Pressure and Lipid Levels: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
Simental-Mendía Luis E, Barragán-Zúñiga Laura Jazel, Reyes-Avitia Valeria
High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension · 2026
PMID: 41582189
Effect of glucagon-like peptide-1 receptor agonists on heart rate in non-diabetic individuals with overweight or obesity: a systematic review and pairwise and network meta-analysis of randomized controlled trials.
Zhang Yiwen, Zhang Chuying, Gong Xuyang et al.
European journal of medical research · 2026
PMID: 42385950
Effects of retatrutide on learning and memory in streptozotocin-induced male diabetic rats.
Keskin Ulya, Altın Eslem, Kara Melkan Kağan et al.
Behavioural brain research · 2026
PMID: 42529769
Efficacy and Safety of Dual and Triple Glucagon-Like Peptide-1-Based Polyagonists in Metabolic Dysfunction-Associated Steatotic Liver Disease and Steatohepatitis: A Systematic Review and Meta-Analysis.
Santos Solis Rogelio, Baeza-Zapata Armando A, Negrete-Najar Juan P
Cureus · 2026
PMID: 42394981
Efficacy and safety of incretin-based therapies in patients with type 2 diabetes mellitus: a network meta-analysis based on clinical trials.
Wu Xichao, Yang Yujiao, Cui Xueyan et al.
Frontiers in pharmacology · 2026
PMID: 42250575
Efficacy and safety of retatrutide, a GIP, GLP-1, and glucagon receptor agonist, in people with type 2 diabetes and inadequate glycaemic control with diet and exercise (TRANSCEND-T2D-1): a double-blind, randomised, phase 3 trial.
Bajaj Harpreet S, Welch Michelle, Shah Parag et al.
Lancet (London, England) · 2026
PMID: 41723268
Efficacy of GLP-1 analog peptides, semaglutide, tirzepatide, and retatrutide on MC4R deficient obesity and their comparison.
Hitaka Kosuke, Sugawara Takumi, Matsumoto Mitsuharu et al.
International journal of obesity (2005) · 2026
PMID: 42165732
Evolution of incretin-based therapies: From GLP-1 monotherapy to dual and triple agonists: A new era in metabolic therapy.
Gupta Monika, Shukla Jitendra
The Indian journal of medical research · 2026
PMID: 41997446
GIPR:GCGR co-agonism restores normal weight in obese rodents.
Perez-Tilve Diego, Zhang Fa, Zhang Yujin et al.
Molecular metabolism · 2026
PMID: 42318576
GLP-1 Agonists in Adolescent Obesity: A Narrative Review of Single, Dual, and Triple Agonists.
Abid Mahroz, Sheikh Khizer Sohail, Ahmad Muhammad Shahbaz et al.
Diabetes, metabolic syndrome and obesity : targets and therapy · 2026
PMID: 42568490
Incretin analogues as cardiovascular agents: a state-of-the-art review.
Araiza-Garaygordobil Diego, Rico-Fontalvo Jorge, Hernández-Balbuena Betsabe et al.
Frontiers in endocrinology · 2026
PMID: 41711462
Incretin-Based Dual and Triple Agonists in Overweight or Obese Individuals: A Systematic Review and Meta-Analysis.
Chan Zhi Hong, Omar Abdousamad Said, Gill Kieran et al.
Cardiology in review · 2026
PMID: 42562129
Integrating GLP-1 Receptor Agonists Into Dermatology Practice: Safety and Monitoring Strategies.
Narla Shanthi, Narla Radhika R
Clinics in dermatology · 2026
PMID: 42156758
Kynurenic acid mediates epicardial fat-induced lymphatic metabolic dysfunction in atrial fibrillation.
Takahashi Masaki, Abe Ichitaro, Yoshida Naofumi et al.
Nature communications · 2026
PMID: 42444567
Medical Treatments for Obesity: What Does the Future Have in Store?
Bassatne Aya, Rizo Ivania
The Journal of clinical endocrinology and metabolism · 2026
PMID: 42195239
Metabolic Dysfunction-Associated Steatotic Liver Disease and Incretin Receptor Agonists: A Metabolic Approach to Halting Liver Disease Progression.
Abenavoli Ludovico, Loricchio Anna Giulia, Lopez Ivo et al.
Medicina (Kaunas, Lithuania) · 2026
PMID: 42037991
Metabolic inflammation at the adipose-brain axis.
Mateus-Gomes Saudina, Al-Sayyar Amnah, Lobey Baptiste et al.
Frontiers in physiology · 2026
PMID: 41964043
Multi-omic profiling reveals Retatrutide alleviates adipose tissue fibrosis via metabolic reprogramming and tissue repair.
Li Qingyang, Cheng Weilun, Zhang Jingyan et al.
Diabetology & metabolic syndrome · 2026
PMID: 41547240
Multi-target incretin-based therapeutics: The rise of dual and triple agonists for metabolic disorders.
Alavi Seyed Ebrahim, Boshrouyeh Reza, Raza Aun et al.
European journal of medicinal chemistry · 2026
PMID: 41901137
New Drugs on the Block: Dietary Management and Nutritional Considerations During the Use of Anti-Obesity Medication.
Pardali Eleni C, Gkouskou Kalliopi K, Cholevas Christos et al.
Nutrients · 2026
PMID: 41948476
Obesity pharmacotherapy reimagined: The era of multi-receptor agonists and next-generation metabolic modulators, perspectives and controversies.
Lempesis Ioannis G, Dalamaga Maria
Metabolism open · 2026
PMID: 41831086
Pharmacologic Treatment of Metabolic Dysfunction-Associated Steatotic Liver Disease in the Context of Type 2 Diabetes.
Malandris Konstantinos, Charalampidis Konstantinos, Loomba Rohit et al.
Current diabetes reports · 2026
PMID: 42135195
Retatrutide And Lipid And Metabolite Profiles In Participants With Obesity With Or Without Type 2 Diabetes.
Pearson Mackenzie J, Willency Jill A, Lin Yanzhu et al.
The Journal of clinical endocrinology and metabolism · 2026
PMID: 41741376
Retatrutide Shows Multiple Metabolic Benefits in Diet-Induced Obese MASH Mouse and Hamster Models.
Briand François, Le Cudennec Camille, Grasset Estelle et al.
Obesity (Silver Spring, Md.) · 2026
PMID: 42493254
Retatrutide and the urinary tract infection signal: Is the answer hidden in timing?
Koufakis Theocharis, Argyrakopoulou Georgia, Kokkinos Alexander et al.
European journal of internal medicine · 2026
PMID: 42527705
Retatrutide effects on diabetic rats' cognition.
Ferreira Jorge
Lab animal · 2026
PMID: 42425580
Retatrutide fact check: Has a man died after taking the unapproved weight loss jab?
Mahase Elisabeth
BMJ (Clinical research ed.) · 2026
PMID: 41785010
Retatrutide in type 2 diabetes mellitus and obesity: an overview.
Panou Theodoros, Gouveri Evanthia, Popovic Djordje S et al.
Expert review of clinical pharmacology · 2026
PMID: 42567543
Retatrutide: Obesity drug opens to "compassionate use" in US after speculation Trump took it.
Brown Carolyn
BMJ (Clinical research ed.) · 2026
PMID: 42264536
Retatrutide: Triple acting jab for type 2 diabetes lowers blood sugar and boosts weight loss, trial reports.
Lang Katharine
BMJ (Clinical research ed.) · 2026
PMID: 42249250
Synergistic Intervention for Obesity: Integrating Central Appetite Regulation and Peripheral Energy Expenditure.
Xie Jiayan, Yang Yujing, Chen Wanting et al.
Current obesity reports · 2026
PMID: 41823054
Targeting the LPI/GPR55 Axis in MAFLD and MASH: Novel Insights, Therapeutic Strategies and Future Directions.
Lian Jerome, Lareu Ricky R, Patil Mohan et al.
Liver international : official journal of the International Association for the Study of the Liver · 2026
PMID: 41545327
The Triple-Agonist Revolution: Retatrutide and the Paradigm Shift in Multi-Hormonal Pharmacotherapy for Obesity and Cardiometabolic Comorbidities.
Ganamurali Nila, Sabarathinam Sarvesh
Clinical pharmacology in drug development · 2026
PMID: 42556625
The role of GLP-1 and GIP receptor agonists in the treatment of diabetes and obesity.
Roskoski Robert
Pharmacological research · 2026
PMID: 42108533
Triple Hormone Receptor Agonism: The Role of Retatrutide in Addressing Cardiovascular-Kidney-Metabolic (CKM) Syndrome: A Comprehensive Review.
Pillai Ashwin A, Godin Shea-Lee, Frishman William H et al.
Cardiology in review · 2026
PMID: 42536830
[An historical overview of GLP-1/GIP incretins. From hormone to "swiss-army knife" medications].
Portha Bernard
Biologie aujourd'hui · 2026
PMID: 41540866
[Nephrology : what's new in 2025].
Nanchen Giliane, Pruijm Menno, Lamine Faïza et al.
Revue medicale suisse · 2026
For research use only. This index links to third-party literature. Nothing here constitutes medical advice.